No-fault compensation for transfusion-associated hepatitis B virus, hepatitis C virus, and HIV infection: Italian law and the Tuscan experience

Transfusion

Volumn 38, Issue 6, 1998, Pages 596-601

  Fineschi, V ^a   Cateni, C ^a   Fanetti, P L ^b   Turillazzi, E ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b Regional Military Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DECISION MAKING; HEPATITIS A VIRUS; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; INFECTION RISK; ITALY; LAW; LEGAL ASPECT;

EID: 0031818258     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1998.38698326340.x     Document Type: Article

References (15)

1. Law number 210 of February 25, 1992. [Economic indemnity for persons affected by irreversible pathological impairment following compulsory vaccinations, transfusions, and administration of hemoderivatives.] In: Gazzetta Ufficiale della Repubblica Italiana, 6 March 1992(55):4-5.
2. Turillazzi E, Cateni C. [Voluntary and compulsory sanitary treatments.] In: Barni M, ed. La tutela della salute nella giurisprudenza della Corte Costituzionale. Turin: C.G. Edizioni Medico-Scientifiche, 1996:43-101.
3. Ponzanelli G, Busato A. [Comment on Law 210 of 1992. Statement: a plan of social security.] Il Corriere Giuridico 1992;9:954-8.
4. Sirchia G, Giovanetti AM, Parravicini A, et al. Prospective evaluation of posttransfusion hepatitis. Transfusion 1991;37:299-302.
5. Bruni P, De Palma T, Fanetti P, Fineschi V. [Physical impairment due to vaccinations and blood transfusions: doctrinaire statements and criteria for evaluation] (Engl abstract). Riv Ital Med Legale 1996;2:509-25.
6. Ministry of Health. [Safe and good use of blood] (Engl abstract). Rome: National Committee for Transfusion Services, 1993.
7. Mele A, Rosmini F, Zampieri A, Gill ON. Integrated epidemiological system for acute viral hepatitis in Italy (SEIEVA): description and preliminary results. Eur J Epidemiol 1986;2:300-4.
8. Ministry of Health. Decree of December 27,1990. In: Gazzetta Ufficiale della Repubblica Italiana, 24 January 1991(20):6-11.
9. McCullough J. National blood programs in developed countries. Transfusion 1996;36:1019-32.
10. Parravicini A. [The well-known and less well-known risks of blood transfusion] (Engl abstract). Profession Sanità Pubblica e Medicina Praitica 1996;2:41-4.
11. Ministry of Health. [AIDS: notified cases in Italy as of June 30, 1996.] Boll Farmacodip AlcooTis 1996;19:63-70.
12. Lackritz EM, Satten GA, Aberle-Grasse J, et al. Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States. N Engl J Med 1995;333:1721-5.
13. Busch MP, Lee LLL, Satten GA, et al. Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors. Transfusion 1995;35:91-7.
14. Law number 107 of May 4, 1990. Regulation of transfusional activity regarding human blood and its component and for the production of plasma derivatives. In: Gazzetta Ufficiale della Repubblica Italiana, 11 May, 1990(103):5-18.
15. Sirchia G, Giovanetti AM, McClelland DBL, Fracchia GN, eds. Safe and good use of blood in surgery (SANGUIS). Use of blood products and artificial colloids in 43 European hospitals. Brussels: European Commission (EUR 15398 EN), 1994.